Dr. JIE MENG | Neuroscience | Best Researcher AwardĀ
Work Experience š¼:
Jie Meng is currently an Intermediate Researcher at Sichuan University West China Hospital in Chengdu, China, a position held since 2019. In this role, Jie Meng conducts cutting-edge research into neurodegenerative diseases, focusing particularly on Alzheimerās disease and Parkinsonās disease.
Awards and Honors
Jie Mengās exceptional contributions to the field of neuroscience have been recognized with several awards, including the Qinghai Province Science and Technology Award, where he received the Second Prize in Natural Science for his innovative work in neurodegeneration research.
Research Interests:
Jie Mengās research primarily revolves around the mechanisms of neurodegenerative diseases, with a strong emphasis on microglia-mediated neuroinflammation in Alzheimer’s disease (AD). His work seeks to identify novel epigenetic biomarkers for early-onset Parkinsonās disease (PD) and explore therapeutic strategies aimed at mitigating chronic neuroinflammation.,Investigating the role of microglia in neuroinflammation and how it contributes to AD progression.,Exploring epigenetic biomarkers that can aid in the early detection of Parkinsonās disease.,Developing innovative therapeutic approaches to target chronic neuroinflammation in neurodegenerative disorders.
š PublicationĀ
- Testing cognitive normal for Alzheimer’s disease prediction
Citations: 0
Year: 2025
Authors: Meng, J., Lei, P.
Journal: Journal of Neurochemistry
- Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke
Citations: 2
Year: 2024
Authors: Du, B., Deng, Z., Chen, K., Tuo, Q.-Z., Lei, P.
Journal: Genes and Diseases
- How brain ācleanersā fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer’s disease
Citations: 12
Year: 2024
Authors: Ni, J., Xie, Z., Quan, Z., Meng, J., Qing, H.
Journal: GLIA
- Thrombin induces ferroptosis in triple-negative breast cancer through the cPLA2Ī±/ACSL4 signaling pathway
Citations: 5
Year: 2024
Authors: Xu, S., Tuo, Q.-Z., Meng, J., Li, C.-L., Lei, P.
Journal: Translational Oncology
- Leucine-rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule-associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism
Citations: 3
Year: 2023
Authors: Chen, K., Tang, F., Du, B., Lei, P., Wei, X.-W.
Journal: MedComm
- The Dual Nature of Microglia in Alzheimerās Disease: A Microglia-Neuron Crosstalk Perspective
Citations: 8
Year: 2023
Authors: Xie, Z., Meng, J., Wu, Z., Qing, H., Ni, J.
Journal: Neuroscientist
- Scopolamine causes delirium-like brain network dysfunction and reversible cognitive impairment without neuronal loss
Citations: 8
Year: 2023
Authors: Wang, Q., Zhang, X., Guo, Y.-J., Yue, J.-R., Lei, P.
Journal: Zoological Research
- Microglial cathepsin E plays a role in neuroinflammation and amyloid Ī² production in Alzheimerās disease
Citations: 14
Year: 2022
Authors: Xie, Z., Meng, J., Kong, W., Qing, H., Ni, J.
Journal: Aging Cell
- Differential Expression and Distinct Roles of Proteinase-Activated Receptor 2 in Microglia and Neurons in Neonatal Mouse Brain After Hypoxia-Ischemic Injury
Citations: 6
Year: 2022
Authors: Liu, Y., Li, H., Hu, J., Qing, H., Ni, J.
Journal: Molecular Neurobiology
- Nucleus distribution of cathepsin B in senescent microglia promotes brain aging through degradation of sirtuins
Citations: 28
Year: 2020
Authors: Meng, J., Liu, Y., Xie, Z., Lei, P., Ni, J.
Journal: Neurobiology of Aging
ConclusionĀ